With increasing life span, Lumbar Spinal Stenosis (LSS) is also increasing. Despite various treatment methods, many limitations remain unsolved.
Wonli Acupuncture, the new technic invented by Geon-mok Lee at Dr. Lee RATOC, began to receive attention from academia as a new treatment method for Lumbar spinal stenosis. This technic is invented from understanding the human anatomy and ancient tools of acupuncture.
This June, the research on Wonli Acupuncture was published on journal of Evidence-based Complementary and Alternative Medicine(SCI). They investigated clinical efficacy of Wonli Acupuncture for the patients with LSS. A total of 82 patients with LSS not relieved from other treatment like injections were treated with Wonli Acupuncture. Out of those, 47 patients without exclusion criteria were selected for the following research. Pre-treatment VAS and ODI scores with one year follow-up measurements were compared and both score were statistically improved. Moreover, more than 50% of the patients’ ODI score was improved over 50%.
Technic of Wonli Acupuncture exfoliates the synechia widening the spinal canal physically with round tipped acupuncture. It can reduce the pressure on nerves and improve the symptoms without harming the nerves and vessels. Wonli Acupuncture suggests an alternative way for spinal surgery which arise many side-effects like Failed Back Surgery Syndrome.
This procedure can be applied over and over again whenever the symptom reoccurs and it is applicable not only to lateral foraminal stenosis but also to central, lateral recess, foraminal, and extraforaminal region. It is also useful to other degenerative spinal disease like HIVD and joint diseases with same mechanism.
Dr. Geon-mok Lee said “The safety of Wonli Acupuncture was proved with more than 11,000 cases. The efficacy was confirmed through research on SCI journal.”
The research can be found on Hindawi online by ‘Effects of Wonli Acupuncture procedure in patients with LSS: clinical, retrospective study.’ Wonli Acupuncture is patented in Korea, Europe, Japan, and is currently patent pending in US.